The Blood-Brain Barrier and Alzheimer’s Disease

doi:10.3969/j.issn.2095-1396.2022.04.006

ACTA NEUROPHARMACOLOGICA ›› 2022, Vol. 12 ›› Issue (4): 58-64.DOI: 10.3969/j.issn.2095-1396.2022.04.006

The Blood-Brain Barrier and Alzheimer’s Disease

LV Xue-ying，ZHANG Zheng，LUO Huan-min

1. Yunkang School of Medicine and Health，Nanfang College，Guangzhou，510970，China 2. Department of Pharmacy，the First Affiliated Hospital of Jinan University，Guangzhou，510630，China 3. Department of Pharmacology， School of Medicine，Jinan University，Guangzhou，510632，China

Online:2022-08-26 Published:2023-08-30

Abstract

Abstract:

Alzheimer’s disease is still a difficult problem in medical field since its discovery. This article reviews the relationship between blood-brain barrier （BBB） and Alzheimer’s disease. A large number of studies have identified elevated BBB leakage in Alzheimer’s disease patients，and ApoE4 is the strongest genetic risk factor for late onset Alzheimer’s disease. This paper focuses on the causes of BBB damage and how to repair BBB to achieve the therapeutic effect of Alzheimer’s disease.

Key words: blood-brain barrier, permeability, Alzheimer’s disease, ApoE4, β-amyloid deposition, microglia, inflammation

LV Xue-ying, ZHANG Zheng, LUO Huan-min. The Blood-Brain Barrier and Alzheimer’s Disease[J]. ACTA NEUROPHARMACOLOGICA, 2022, 12(4): 58-64.

[1]	CHEN Bin-feng, LIN Feng. Efficacy of Honeysuckle Oral Liquid Combined with Oseltamivir in the Treatment of Hand-foot-mouth Disease in Children and Its Effect on Inflammatory Factors and Immune Function [J]. ACTA NEUROPHARMACOLOGICA, 2022, 12(6): 35-39.
[2]	SI Wen-ying, HOU Yu-qing, SUN Xiao-jing, MENG Xian-yong, DONG Xiao-hua. Gene Therapy for Alzheimer’s Disease [J]. ACTA NEUROPHARMACOLOGICA, 2022, 12(6): 51-56.
[3]	ZHANG Zhi-qing, ZHANG Yong-cai, LIU Lin-xuan, LI Ren-qing, LIU Ji-jia, DU Jing-kao, JIANG Bei, WEI Huiping, SU Li-ning. Bioinformatics Analysis of the Relationship between Exosomal ceRNA Regulatory Network and Alzheimer’s Disease [J]. ACTA NEUROPHARMACOLOGICA, 2022, 12(4): 23-40.
[4]	CAI Yu-shan, ZHAO Shuai. Role of PPARβ/δ in Neurodegenerative Diseases [J]. ACTA NEUROPHARMACOLOGICA, 2022, 12(4): 41-48.
[5]	LI Chen-yang, ZHAO Jiao-jiao, ZHANG Wei. Research Progress in Regulation of Central Nervous System Function by Radix Bupleuri and Scutellaria Baicalensis [J]. ACTA NEUROPHARMACOLOGICA, 2022, 12(4): 49-57.
[6]	WANG Jia-qi, WU Lu-lu, ZHANG Fei-fei, GAO Man, DANG Yi, QI Xiao-yong. Research Progress of Inflammatory Related Derivative Indices and Acute Myocardial Infarction [J]. ACTA NEUROPHARMACOLOGICA, 2022, 12(3): 11-.
[7]	LIU Yang-bo, CHEN Hao-dong, FENG Ju-ling, CHU Shi-feng, CHEN Nai-hong. Regulation of Neuroinflammation by Chemokine Receptors in Post Stroke Stage [J]. ACTA NEUROPHARMACOLOGICA, 2021, 11(4): 32-.
[8]	JIA Zhen-jie, YANG Xin-ming, DING Peng-hui. Research Progress on Anti-Inflammatory Drugs and Lumbar Intervertebral Disc Herniation [J]. ACTA NEUROPHARMACOLOGICA, 2021, 11(4): 58-.
[9]	DAI Yue-ying, ZHAO Yu-wei, YAO Si-fan, SHEN Li-xia. Neuroprotective Effect of Estrogen-Mediated Mitochondrial Pathway [J]. ACTA NEUROPHARMACOLOGICA, 2021, 11(3): 33-42.
[10]	SUN Ting, XIE Jia-jia, ZHANG Dan-shen. Research Progress of Mitochondrial Permeability Transition Pore in Cerebral Ischemia-Reperfusion Injury [J]. ACTA NEUROPHARMACOLOGICA, 2021, 11(2): 26-31.
[11]	LIAO Yu-mei, XUE Ya-dong, CHEN Sheng, et al. Research Progress of Anti-inflammatory Activity of PPARs Agonist in the Treatment of Depression [J]. ACTA NEUROPHARMACOLOGICA, 2021, 11(2): 32-38.
[12]	DING Sheng-kai, LIU Qing-qing, LIU Xin-yang, SHANG Ya-zhen. Relationship between Adult Hippocampus Neurogenesis and Alzheimer’s Disease [J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(6): 48-53.
[13]	HUANG Ying, HUO Yan-li, MING Yue, HAO Jun-rong. Research Progress of High-Fat Diet and Alzheimer’s Disease [J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(6): 54-59.
[14]	XIE bin, HUANG Zhi-yuan, LIN Duo-duo, YANG Fu-long, XIE Yi-bin. Effect of Acupuncture Combined with Medicine on Depressive Symptoms of Alzheimer’s Disease [J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(5): 5-8.
[15]	SUN Li-cong, ZHANG Dan-shen. Research Progress on Potential Treatment of Alzheimer’s Disease with Alkaloids [J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(5): 33-37.

The Blood-Brain Barrier and Alzheimer’s Disease

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics